182 -4 (78) 2025 - Badritdinova M.N., Pulatova SH.H. - A METHOD FOR COMPARATIVE ANALYSIS OF THE CAUSES OF MORTALITY AFTER CORONARY ARTERY BYPASS SURGERY AND PERCUTANEOUS CORONARY INTERVENTION IN COMPLICATED CORONARY ARTERY DISEASE

A METHOD FOR COMPARATIVE ANALYSIS OF THE CAUSES OF MORTALITY AFTER CORONARY ARTERY BYPASS SURGERY AND PERCUTANEOUS CORONARY INTERVENTION IN COMPLICATED CORONARY ARTERY DISEASE

Badritdinova M.N. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Pulatova SH.H. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Shamsiev K.Y. - Bukhara State Medical Institute named after Abu Ali ibn Sina, Bukhara branch of the Republican Scientific Center for Emergency Medical Care Uzbekistan

Resume

In patients with complicated ischemic heart disease, myocardial revascularization through coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) is currently regarded as the optimal treatment method [1]. Numerous studies report the outcomes of CABG and PCI as optimal treatment strategies or compare their effectiveness [2]; however, data regarding the causes, conditions, and mechanisms of mortality following these complex procedures remain limited. Objective The aim of this study is to investigate the specific causes of mortality following revascularization and its predictors in patients with complicated coronary artery disease. Materials and Methods Our study is a randomized trial encompassing central and peripheral branches. In each center, anticipated patients with clinical conditions were randomly selected for CABG and PCI procedures based on the clinical judgment and consensus of a cardiac team comprising cardiac surgeons and interventional cardiologists (CABG, n=805; PCI, n=871). Study Results Over a four-year follow-up period after PCI and CABG procedures, 94 and 74 mortality cases were recorded, respectively. The majority of deaths were associated with cardiovascular diseases (52.97%, n=89) [Table 1]. Following PCI, the primary cause of cardiovascular mortality was linked to myocardial infarction (MI) [Figure 1A]. In the CABG group, cardiovascular mortality accounted for 40.54% (n=30), non-cardiovascular mortality for 52.70% (n=39), and in 2.7% of cases (n=2), the cause of death was classified as undetermined [Table 1]. Among cardiovascular deaths, only a few were attributed to vascular causes. The predominant causes of cardiovascular mortality following CABG included chronic heart failure, arrhythmias, and other factors.

Keywords: Coronary artery bypass grafting, percutaneous coronary intervention, myocardial infarction, chronic heart failure, mortality rate

First page

1017

Last page

1027

For citation:Badritdinova M.N., Pulatova SH.H., Shamsiev K.Y. - A METHOD FOR COMPARATIVE ANALYSIS OF THE CAUSES OF MORTALITY AFTER CORONARY ARTERY BYPASS SURGERY AND PERCUTANEOUS CORONARY INTERVENTION IN COMPLICATED CORONARY ARTERY DISEASE//New Day in Medicine 4(78)2025 1017-1027 https://newdayworldmedicine.com/en/new_day_medicine/4-78-2025

List of References

1. S. Windecker, P. Kolh, F. Alfonso, et al. b2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)., Eur Heart J, 35 (2014), pp. 2541. View in Scopus Google Scholar.
2. S. Deb, H.C. Wijeysundera, D.T. Ko, H. Tsubota, S. Hill, S.E. Fremes., Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review., JAMA, 310 (2013), pp. 2086. View at publisher Crossref View in Scopus Google Scholar.
3. D.R. Holmes Jr., J.W. Moses, J. Schofer, M.C. Morice, E. Schampaert, M.B. Leon., Cause of death with bare metal and sirolimus-eluting stents., Eur Heart J, 27 (2006), pp. 2815. View at publisher Crossref View in Scopus., Google Scholar.
4. J. Herlitz, G. Brandrup-Wognsen, K. Caidahl, et al. Cause of death during 13 years after coronary artery bypass grafting with emphasis on cardiac death., Scand Cardiovasc J, 38 (2004), pp. 283-286. View in Scopus, Google Scholar.
5. D.R. Holmes Jr., K.B. Davis, M.B. Mock, et al. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study., Circulation, 73 (1986), pp. 1254. View in Scopus., Google Scholar.
6. D.R. Holmes Jr., L.J. Kim, M.M. Brooks, et al. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation., J Thorac Cardiovasc Surg, 134 (2007), pp. 38-4646 e1. View at publisher, Crossref View in Scopus., Google Scholar.
7. S.J. Head, S. Kaul, M.J. Mack, et al. The rationale for heart team decision-making for patients with stable, complex coronary artery disease. Eur Heart J, 34 (2013), pp. 2510. View at publisher Crossref View in Scopus, Google Scholar.
8. P.W.Serruys, M.C. Morice, A.P. Kappetein, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 360 (2009), pp. 961. View at publisher Crossref Google Scholar.
9. A.P. Kappetein, T.E. Feldman, M.J. Mack, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial., Eur Heart J, 32 (2011), pp. 2125-2134. View at publisher Crossref View in Scopus, Google Scholar.
10. S.J. Head, D.R. Holmes Jr., M.J. Mack, et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries., J Am Coll Cardiol Intv, 5 (2012), pp. 618-625. View PDF View article View in Scopus Google Scholar. Qabul qilingan sanа 20.03.2025

    file

    download